Search research articles
Contact Us
Filters
Showing results (81-90 of 212) with videos related to
Page
of 22
Sort By:
Tumori
|
February 28, 1979
Clinical classification and survival in chronic lymphocyte leukemia
A Santoro, R Musumeci, F Rilke, et al.
Tumori
|
May 6, 1999
Fluoropyrimidines in the treatment of advanced neoplastic diseases: role and advantages of UFT
M Del Vecchio, G Procopio, A Cassata, et al.
Cancer Chemotherapy Reports
|
November 1, 1973
Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix
G M de Palo, E Bajetta, L Luciani, et al.
Tumori
|
May 6, 1999
Pharmacokinetics of oral doxifluridine in patients with colorectal cancer
M G Zampino, M Colleoni, E Bajetta, et al.
The International Journal of Biological Markers
|
June 15, 1999
Hormonal regulation of MUC1 expression
E Seregni, C Botti, E Bajetta, et al.
Minerva Endocrinologica
|
January 10, 2002
[Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure?]
E Bombardieri, M Maccauro, M R Castellani, et al.
The British Journal of Surgery
|
December 20, 2005
Pathological features as predictors of recurrence after radical resection of gastric cancer
R Buzzoni, E Bajetta, M Di Bartolomeo, et al.
The Journal of Dermatology
|
September 1, 1992
Classic Kaposi's sarcoma: a review of 90 cases
S Zurrida, C Bartoli, F Nolé, et al.
Cancer Treatment Reports
|
February 1, 1976
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease
G Beretta, G Bonadonna, E Bajetta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research
R D Rubens, E Bajetta, J Bonneterre, et al.
Page
of 22
Search research articles
Search
Showing results (81-90 of 212) with videos related to
Sort By:
Page
of 22
Tumori
|
February 28, 1979
Clinical classification and survival in chronic lymphocyte leukemia
A Santoro, R Musumeci, F Rilke, et al.
Tumori
|
May 6, 1999
Fluoropyrimidines in the treatment of advanced neoplastic diseases: role and advantages of UFT
M Del Vecchio, G Procopio, A Cassata, et al.
Cancer Chemotherapy Reports
|
November 1, 1973
Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix
G M de Palo, E Bajetta, L Luciani, et al.
Tumori
|
May 6, 1999
Pharmacokinetics of oral doxifluridine in patients with colorectal cancer
M G Zampino, M Colleoni, E Bajetta, et al.
The International Journal of Biological Markers
|
June 15, 1999
Hormonal regulation of MUC1 expression
E Seregni, C Botti, E Bajetta, et al.
Minerva Endocrinologica
|
January 10, 2002
[Radioisotopic imaging of neuroendocrine tumours. Which radiopharmaceutical and which diagnostic procedure?]
E Bombardieri, M Maccauro, M R Castellani, et al.
The British Journal of Surgery
|
December 20, 2005
Pathological features as predictors of recurrence after radical resection of gastric cancer
R Buzzoni, E Bajetta, M Di Bartolomeo, et al.
The Journal of Dermatology
|
September 1, 1992
Classic Kaposi's sarcoma: a review of 90 cases
S Zurrida, C Bartoli, F Nolé, et al.
Cancer Treatment Reports
|
February 1, 1976
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease
G Beretta, G Bonadonna, E Bajetta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Treatment of relapse of breast cancer after adjuvant systemic therapy--review and guidelines for future research
R D Rubens, E Bajetta, J Bonneterre, et al.
Page
of 22